Global Perinatal Infections Market Size Study & Forecast, by Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others), By Diagnosis (Maternal Test, Neonatal Test, Others), By Treatment (Antibiotics, Antiviral, Antiretroviral, Others), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospitals, Homecare, Specialty Clinics), and Regional Analysis, 2023-2030
Global Perinatal Infections Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Perinatal infections are infections that occur during pregnancy or shortly after delivery, which can be transmitted from the mother to the fetus or newborn. These infections is generally caused by bacteria, viruses, fungi, or parasites that exhibit a serious impact on both the mother and the infant. Several common perinatal infections include cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, others. The surging cases of perinatal infections, growing awareness regarding treatment availability, rising number of government initiatives, spurring demand for personalized medicine, rising inclination towards point-of-care testing are the most prominent factors that are propelling the market demand across the globe.
In addition, the rising incidences of Human Immunodeficiency Virus (HIV) are exhibiting a positive influence on market growth across the globe. Pregnant women with HIV require antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission of the virus. Without proper treatment, the risk of transmission is high and leads to perinatal HIV infection, which can have serious health consequences for the newborn. According to HIV.gov, in 2021it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thereby, the growing awareness and initiatives for HIV prevention and treatment, along with the availability of ART is aids in lessening the chances of perinatal HIV infection, which, in turn, accelerates the global market growth. Moreover, the growing demand for retail pharmacies, as well as the increasing technological advancements in diagnostic tests presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and high cost involved in treatment are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Perinatal Infections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.
Major market players included in this report are:
Merck KGaA (Germany)
Beckman Coulter Inc. (U.S.)
BIOMERIEUX (France)
Bio-Rad Laboratories, Inc (U.S.)
Danaher (U.S.)
Hologic Inc. (U.S.)
Gilead Sciences, Inc. (U.S.)
Emcure Pharmaceuticals Limited. (India)
Cipla Inc. (U.S.)
Johnson & Johnson Private Limited (U.S.)
Recent Developments in the Market:
In October 2021, Gilead Sciences, Inc. unveiled that the Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) has received U.S. Food and Drug Administration (FDA) approval for a new low-dose tablet dosage form for children and adolescents that are virologically suppressed or new to antiretroviral therapy and weigh between 14 kg and 25 kg. By approving this supplemental New Drug Application (sNDA), Biktarvy's indication has been extended to encompass younger children who are HIV-infected, bridging the gap between paediatric and adult HIV treatment alternatives.
Global Perinatal Infections Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Infection Type, Diagnosis, Treatment, Route of Administration, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Infection Type:
Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others
By Diagnosis:
Maternal Test
Neonatal Test
Others
By Treatment:
Antibiotics
Antiviral
Antiretroviral
Others
By Route of Administration:
Oral
Parenteral
Others
By End-user:
Hospitals
Homecare
Specialty Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
In addition, the rising incidences of Human Immunodeficiency Virus (HIV) are exhibiting a positive influence on market growth across the globe. Pregnant women with HIV require antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission of the virus. Without proper treatment, the risk of transmission is high and leads to perinatal HIV infection, which can have serious health consequences for the newborn. According to HIV.gov, in 2021it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thereby, the growing awareness and initiatives for HIV prevention and treatment, along with the availability of ART is aids in lessening the chances of perinatal HIV infection, which, in turn, accelerates the global market growth. Moreover, the growing demand for retail pharmacies, as well as the increasing technological advancements in diagnostic tests presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and high cost involved in treatment are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Perinatal Infections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.
Major market players included in this report are:
Merck KGaA (Germany)
Beckman Coulter Inc. (U.S.)
BIOMERIEUX (France)
Bio-Rad Laboratories, Inc (U.S.)
Danaher (U.S.)
Hologic Inc. (U.S.)
Gilead Sciences, Inc. (U.S.)
Emcure Pharmaceuticals Limited. (India)
Cipla Inc. (U.S.)
Johnson & Johnson Private Limited (U.S.)
Recent Developments in the Market:
In October 2021, Gilead Sciences, Inc. unveiled that the Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) has received U.S. Food and Drug Administration (FDA) approval for a new low-dose tablet dosage form for children and adolescents that are virologically suppressed or new to antiretroviral therapy and weigh between 14 kg and 25 kg. By approving this supplemental New Drug Application (sNDA), Biktarvy's indication has been extended to encompass younger children who are HIV-infected, bridging the gap between paediatric and adult HIV treatment alternatives.
Global Perinatal Infections Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Infection Type, Diagnosis, Treatment, Route of Administration, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Infection Type:
Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others
By Diagnosis:
Maternal Test
Neonatal Test
Others
By Treatment:
Antibiotics
Antiviral
Antiretroviral
Others
By Route of Administration:
Oral
Parenteral
Others
By End-user:
Hospitals
Homecare
Specialty Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Perinatal Infections Market, by Region, 2020-2030 (USD Billion)
1.2.2. Perinatal Infections Market, by Infection Type, 2020-2030 (USD Billion)
1.2.3. Perinatal Infections Market, by Diagnosis, 2020-2030 (USD Billion)
1.2.4. Perinatal Infections Market, by Treatment, 2020-2030 (USD Billion)
1.2.5. Perinatal Infections Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Perinatal Infections Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PERINATAL INFECTIONS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PERINATAL INFECTIONS MARKET DYNAMICS
3.1. Perinatal Infections Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surging cases of perinatal infections
3.1.1.2. Rising incidences of Human Immunodeficiency Virus (HIV)
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.2.2. High cost involved in the treatment
3.1.3. Market Opportunities
3.1.3.1. Growing demand for retail pharmacies
3.1.3.2. Increasing technological advancements in diagnostic tests
CHAPTER 4. GLOBAL PERINATAL INFECTIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION TYPE
5.1. Market Snapshot
5.2. Global Perinatal Infections Market by Infection Type, Performance - Potential Analysis
5.3. Global Perinatal Infections Market Estimates & Forecasts by Infection Type 2020-2030 (USD Billion)
5.4. Perinatal Infections Market, Sub Segment Analysis
5.4.1. Cytomegalovirus Infection
5.4.2. Enterovirus Infection
5.4.3. Genital Herpes
5.4.4. Gonorrhoea
5.4.5. Human Immunodeficiency Virus
5.4.6. Others
CHAPTER 6. GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS
6.1. Market Snapshot
6.2. Global Perinatal Infections Market by Diagnosis, Performance - Potential Analysis
6.3. Global Perinatal Infections Market Estimates & Forecasts by Diagnosis 2020-2030 (USD Billion)
6.4. Perinatal Infections Market, Sub Segment Analysis
6.4.1. Maternal Test
6.4.2. Neonatal Test
6.4.3. Others
CHAPTER 7. GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT
7.1. Market Snapshot
7.2. Global Perinatal Infections Market by Treatment, Performance - Potential Analysis
7.3. Global Perinatal Infections Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
7.4. Perinatal Infections Market, Sub Segment Analysis
7.4.1. Antibiotics
7.4.2. Antiviral
7.4.3. Antiretroviral
7.4.4. Others
CHAPTER 8. GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Perinatal Infections Market by Route of Administration, Performance - Potential Analysis
8.3. Global Perinatal Infections Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Perinatal Infections Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Others
CHAPTER 9. PERINATAL INFECTIONS MARKET, BY END-USER
9.1. Market Snapshot
9.2. Global Perinatal Infections Market by End-user, Performance - Potential Analysis
9.3. Global Perinatal Infections Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
9.4. Perinatal Infections Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Homecare
9.4.3. Specialty Clinics
CHAPTER 10. GLOBAL PERINATAL INFECTIONS MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Perinatal Infections Market, Regional Market Snapshot
10.4. North America Perinatal Infections Market
10.4.1. U.S. Perinatal Infections Market
10.4.1.1. Infection Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Diagnosis breakdown estimates & forecasts, 2020-2030
10.4.1.3. Treatment breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030
10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Perinatal Infections Market
10.5. Europe Perinatal Infections Market Snapshot
10.5.1. U.K. Perinatal Infections Market
10.5.2. Germany Perinatal Infections Market
10.5.3. France Perinatal Infections Market
10.5.4. Spain Perinatal Infections Market
10.5.5. Italy Perinatal Infections Market
10.5.6. Rest of Europe Perinatal Infections Market
10.6. Asia-Pacific Perinatal Infections Market Snapshot
10.6.1. China Perinatal Infections Market
10.6.2. India Perinatal Infections Market
10.6.3. Japan Perinatal Infections Market
10.6.4. Australia Perinatal Infections Market
10.6.5. South Korea Perinatal Infections Market
10.6.6. Rest of Asia Pacific Perinatal Infections Market
10.7. Latin America Perinatal Infections Market Snapshot
10.7.1. Brazil Perinatal Infections Market
10.7.2. Mexico Perinatal Infections Market
10.8. Middle East & Africa Perinatal Infections Market
10.8.1. Saudi Arabia Perinatal Infections Market
10.8.2. South Africa Perinatal Infections Market
10.8.3. Rest of Middle East & Africa Perinatal Infections Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Merck KGaA (Germany)
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Beckman Coulter Inc. (U.S.)
11.3.3. BIOMERIEUX (France)
11.3.4. Bio-Rad Laboratories, Inc (U.S.)
11.3.5. Danaher (U.S.)
11.3.6. Hologic Inc. (U.S.)
11.3.7. Gilead Sciences, Inc. (U.S.)
11.3.8. Emcure Pharmaceuticals Limited. (India)
11.3.9. Cipla Inc. (U.S.)
11.3.10. Johnson & Johnson Private Limited (U.S.)
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Perinatal Infections Market, by Region, 2020-2030 (USD Billion)
1.2.2. Perinatal Infections Market, by Infection Type, 2020-2030 (USD Billion)
1.2.3. Perinatal Infections Market, by Diagnosis, 2020-2030 (USD Billion)
1.2.4. Perinatal Infections Market, by Treatment, 2020-2030 (USD Billion)
1.2.5. Perinatal Infections Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Perinatal Infections Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PERINATAL INFECTIONS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PERINATAL INFECTIONS MARKET DYNAMICS
3.1. Perinatal Infections Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surging cases of perinatal infections
3.1.1.2. Rising incidences of Human Immunodeficiency Virus (HIV)
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.2.2. High cost involved in the treatment
3.1.3. Market Opportunities
3.1.3.1. Growing demand for retail pharmacies
3.1.3.2. Increasing technological advancements in diagnostic tests
CHAPTER 4. GLOBAL PERINATAL INFECTIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION TYPE
5.1. Market Snapshot
5.2. Global Perinatal Infections Market by Infection Type, Performance - Potential Analysis
5.3. Global Perinatal Infections Market Estimates & Forecasts by Infection Type 2020-2030 (USD Billion)
5.4. Perinatal Infections Market, Sub Segment Analysis
5.4.1. Cytomegalovirus Infection
5.4.2. Enterovirus Infection
5.4.3. Genital Herpes
5.4.4. Gonorrhoea
5.4.5. Human Immunodeficiency Virus
5.4.6. Others
CHAPTER 6. GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS
6.1. Market Snapshot
6.2. Global Perinatal Infections Market by Diagnosis, Performance - Potential Analysis
6.3. Global Perinatal Infections Market Estimates & Forecasts by Diagnosis 2020-2030 (USD Billion)
6.4. Perinatal Infections Market, Sub Segment Analysis
6.4.1. Maternal Test
6.4.2. Neonatal Test
6.4.3. Others
CHAPTER 7. GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT
7.1. Market Snapshot
7.2. Global Perinatal Infections Market by Treatment, Performance - Potential Analysis
7.3. Global Perinatal Infections Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
7.4. Perinatal Infections Market, Sub Segment Analysis
7.4.1. Antibiotics
7.4.2. Antiviral
7.4.3. Antiretroviral
7.4.4. Others
CHAPTER 8. GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Perinatal Infections Market by Route of Administration, Performance - Potential Analysis
8.3. Global Perinatal Infections Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Perinatal Infections Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Others
CHAPTER 9. PERINATAL INFECTIONS MARKET, BY END-USER
9.1. Market Snapshot
9.2. Global Perinatal Infections Market by End-user, Performance - Potential Analysis
9.3. Global Perinatal Infections Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
9.4. Perinatal Infections Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Homecare
9.4.3. Specialty Clinics
CHAPTER 10. GLOBAL PERINATAL INFECTIONS MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Perinatal Infections Market, Regional Market Snapshot
10.4. North America Perinatal Infections Market
10.4.1. U.S. Perinatal Infections Market
10.4.1.1. Infection Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Diagnosis breakdown estimates & forecasts, 2020-2030
10.4.1.3. Treatment breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030
10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Perinatal Infections Market
10.5. Europe Perinatal Infections Market Snapshot
10.5.1. U.K. Perinatal Infections Market
10.5.2. Germany Perinatal Infections Market
10.5.3. France Perinatal Infections Market
10.5.4. Spain Perinatal Infections Market
10.5.5. Italy Perinatal Infections Market
10.5.6. Rest of Europe Perinatal Infections Market
10.6. Asia-Pacific Perinatal Infections Market Snapshot
10.6.1. China Perinatal Infections Market
10.6.2. India Perinatal Infections Market
10.6.3. Japan Perinatal Infections Market
10.6.4. Australia Perinatal Infections Market
10.6.5. South Korea Perinatal Infections Market
10.6.6. Rest of Asia Pacific Perinatal Infections Market
10.7. Latin America Perinatal Infections Market Snapshot
10.7.1. Brazil Perinatal Infections Market
10.7.2. Mexico Perinatal Infections Market
10.8. Middle East & Africa Perinatal Infections Market
10.8.1. Saudi Arabia Perinatal Infections Market
10.8.2. South Africa Perinatal Infections Market
10.8.3. Rest of Middle East & Africa Perinatal Infections Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Merck KGaA (Germany)
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Beckman Coulter Inc. (U.S.)
11.3.3. BIOMERIEUX (France)
11.3.4. Bio-Rad Laboratories, Inc (U.S.)
11.3.5. Danaher (U.S.)
11.3.6. Hologic Inc. (U.S.)
11.3.7. Gilead Sciences, Inc. (U.S.)
11.3.8. Emcure Pharmaceuticals Limited. (India)
11.3.9. Cipla Inc. (U.S.)
11.3.10. Johnson & Johnson Private Limited (U.S.)
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Perinatal Infections Market, report scope
TABLE 2. Global Perinatal Infections Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Perinatal Infections Market estimates & forecasts by Infection Type 2020-2030 (USD Billion)
TABLE 4. Global Perinatal Infections Market estimates & forecasts by Diagnosis 2020-2030 (USD Billion)
TABLE 5. Global Perinatal Infections Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
TABLE 6. Global Perinatal Infections Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 7. Global Perinatal Infections Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 8. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Perinatal Infections Market
TABLE 73. List of primary sources, used in the study of global Perinatal Infections Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Perinatal Infections Market, report scope
TABLE 2. Global Perinatal Infections Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Perinatal Infections Market estimates & forecasts by Infection Type 2020-2030 (USD Billion)
TABLE 4. Global Perinatal Infections Market estimates & forecasts by Diagnosis 2020-2030 (USD Billion)
TABLE 5. Global Perinatal Infections Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
TABLE 6. Global Perinatal Infections Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 7. Global Perinatal Infections Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 8. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Perinatal Infections Market
TABLE 73. List of primary sources, used in the study of global Perinatal Infections Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Perinatal Infections Market, research methodology
FIG 2. Global Perinatal Infections Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Perinatal Infections Market, key trends 2022
FIG 5. Global Perinatal Infections Market, growth prospects 2023-2030
FIG 6. Global Perinatal Infections Market, porters 5 force model
FIG 7. Global Perinatal Infections Market, pest analysis
FIG 8. Global Perinatal Infections Market, value chain analysis
FIG 9. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Perinatal Infections Market, regional snapshot 2020 & 2030
FIG 15. North America Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 16. Europe Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Perinatal Infections Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Perinatal Infections Market, research methodology
FIG 2. Global Perinatal Infections Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Perinatal Infections Market, key trends 2022
FIG 5. Global Perinatal Infections Market, growth prospects 2023-2030
FIG 6. Global Perinatal Infections Market, porters 5 force model
FIG 7. Global Perinatal Infections Market, pest analysis
FIG 8. Global Perinatal Infections Market, value chain analysis
FIG 9. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Perinatal Infections Market, regional snapshot 2020 & 2030
FIG 15. North America Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 16. Europe Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Perinatal Infections Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Perinatal Infections Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
